Baxdrostat
D6970C00008
Phase 3 small_molecule completed
Quick answer
Baxdrostat for Uncontrolled Hypertension is a Phase 3 program (small_molecule) at AstraZeneca with 2 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Uncontrolled Hypertension
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed